The landscape of personal wellness and aesthetic medicine has experienced a significant shift in recent years, driven largely by consumer demand for preventative health technologies and data-driven longevity solutions. Amid this growing market, aesthetic practitioner Dr Vix Manning has officially launched ReSolve Age, a novel consumer application engineered to help users track systemic inflammation, monitor key biomarkers, and implement targeted lifestyle interventions aimed at supporting healthy ageing. The platform arrives at a time when preventative medicine and internal wellness are increasingly recognized as foundational elements of dermatological and aesthetic health, bridging the gap between clinical diagnostics and daily consumer habits.
Core Functionality and the ReSolve Score
At the centre of the newly launched application is the proprietary ReSolve Score, a dynamic metric designed to synthesize diverse streams of personal health data into a single, actionable daily figure. According to Dr Manning, the score functions as an internal compass, highlighting specific lifestyle, metabolic, and physiological areas that may require immediate attention or long-term modification.
The application aggregates and analyses information from a wide array of consumer technologies and diagnostic tools. Users can seamlessly connect the platform to existing digital health ecosystems, including Apple Health, various wearable fitness and health trackers, and continuous glucose monitors (CGMs). Furthermore, the application is designed to ingest and interpret formal blood test results where available, offering a more comprehensive overview of internal health markers. Rather than serving as a medical diagnostic device, the ReSolve Score is positioned as an educational and behavioral guide. It evaluates multiple pillars of wellness, encompassing nutrition, physical movement, recovery protocols, sleep architecture, skin health, and specific physiological biomarkers.
The Five-Stage Structured Methodology
To guide users through their longevity and anti-inflammatory journeys, ReSolve Age employs a structured, sequential framework comprising five distinct phases. This methodology is designed to move individuals systematically from initial data collection to long-term habit formation and biological resilience.
The first phase, termed Reveal, focuses on establishing a robust baseline from the user’s aggregated data and diagnostic inputs. This stage is intended to provide a clear, unobstructed view of the individual’s current physiological state, identifying overt imbalances or areas of elevated inflammatory load.
Following the initial assessment is the Remove stage. This component is dedicated to identifying and mitigating potential lifestyle, environmental, and dietary contributors to chronic inflammation. By pinpointing specific stressors—such as blood sugar volatility, poor sleep patterns, or inflammatory dietary components—users are equipped to eliminate or reduce their systemic inflammatory burden.
The third phase, Restore, shifts the programmatic focus toward fundamental physiological recovery. This stage emphasizes optimizing nutritional intake, repairing and supporting gut microbiome health, and establishing rigorous sleep hygiene protocols. Gut health and sleep are increasingly understood by medical professionals to be primary regulators of systemic immune response and inflammatory pathways.
Once baseline restoration is underway, the program advances to Rebuild. Dr Manning notes that this phase is specifically crafted to support cellular resilience, enhance mitochondrial function, stimulate collagen production, and optimize cellular energy generation. By targeting mitochondrial health and structural proteins like collagen, the platform addresses both internal metabolic efficiency and external markers of biological ageing.
The final stage of the framework is Resilience. Designed for long-term sustainability, this phase focuses on maintaining the physiological improvements achieved through the preceding steps, ensuring that healthy habits become ingrained lifestyle practices capable of withstanding future stressors.
Background Context and the Evolution of Longevity Tech
The launch of ReSolve Age does not occur in a vacuum; it represents the culmination of a broader industry-wide migration from reactive healthcare to proactive longevity science. For decades, traditional medicine primarily addressed age-related pathologies after clinical presentation. However, the emergence of geroscience—the study of the biological mechanisms of ageing—has shifted clinical perspectives toward early intervention and the mitigation of "inflammageing," a term used by researchers to describe the chronic, low-grade inflammation that develops with advanced age and accelerates tissue degradation.
Aesthetic medicine has undergone a parallel transformation. Practitioners increasingly recognize that topical treatments and minimally invasive procedures can only achieve optimal results when supported by optimal internal health. Dr Manning’s clinical background informed the development of ReSolve Age, drawing directly from her daily practice where patients frequently seek solutions for both aesthetic concerns and systemic vitality.
"How you age on the outside is a direct reflection of what’s happening on the inside," Dr Manning stated during the platform’s rollout. Elaborating on her clinical philosophy, she added, "I built ReSolve Age around the same principle I use with patients in clinic every day: test before you guess. Testing reveals. Action reverses. Results prove."
Chronology of Development and Market Entry
The conceptualization and eventual release of ReSolve Age reflect a multi-year trend toward digitized preventative medicine. While the formal consumer launch marks a major milestone, the foundational principles behind the application have been developed and refined within clinical settings over a significant period.
Initial phases of the project involved synthesizing clinical trial data, dermatological insights, and biomarker research to establish the parameters for the ReSolve Score. The subsequent integration phase focused on ensuring compatibility with major consumer health hardware, such as smartwatches, fitness bands, and continuous glucose monitoring devices, which have seen exponential adoption rates over the past five years.
By late 2023 and early 2024, beta testing among select patient cohorts allowed for the refinement of the five-stage methodology. Feedback from these initial trials emphasized the need for a user-friendly interface that could translate complex biochemical and biomarker data into digestible, daily actionable steps. The official public release makes these clinical-grade monitoring frameworks accessible to a broader consumer audience seeking to manage their biological age and inflammatory metrics independently.
Industry Data and Market Implications
The launch of consumer-facing biomarker and inflammation-tracking applications aligns with robust global market data indicating surging interest in longevity and preventative health. According to recent industry analyses, the global longevity and anti-ageing market is valued in the hundreds of billions of dollars, with digital health applications and wearable diagnostic tools experiencing the fastest growth rates.
Consumers are increasingly willing to invest in personalized health technologies that offer real-time feedback loops. The proliferation of continuous glucose monitors outside of diabetic populations, coupled with the ubiquity of advanced health wearables, has created a technologically literate consumer base eager to interpret their own physiological data.
However, the entry of aesthetic and lifestyle practitioners into the digital health space also prompts important discussions regarding data privacy, medical oversight, and the interpretation of complex biomarkers by laypersons. While applications like ReSolve Age are carefully structured to provide guidance rather than formal medical diagnoses, health economists and digital health analysts note that consumer demand for direct-to-consumer diagnostics will likely necessitate clearer regulatory frameworks in the near future.
Broader Industry Impact and Future Outlook
The introduction of ReSolve Age highlights a blurring of lines between clinical aesthetic practice and consumer health technology. As patients and consumers alike demand a more holistic approach to looking and feeling younger, platforms that connect internal biomarkers—such as inflammation markers and metabolic efficiency—with external vitality are expected to become increasingly mainstream.
For the aesthetic practitioner community, the app exemplifies a new business and care model. Rather than relying solely on procedural interventions, forward-thinking clinicians are packaging their diagnostic philosophies into digital products that allow them to scale their expertise beyond the physical confines of the clinic.
As ReSolve Age establishes its footprint in the competitive wellness app market, its success will likely depend on its ability to maintain user engagement, accurately interpret diverse biometric data streams, and demonstrate tangible improvements in user wellness metrics over time. For Dr Manning and her peers, the broader mission remains clear: shifting the cultural paradigm of ageing from an inevitable decline to a manageable, measurable, and optimizable biological process.
